Trade TEVA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) is trading at US$37.26, down 0.96% today as of Aug 28, 09:35 EDT. The company has a market capitalisation of US$43.51B. Over the past 52 weeks, TEVA has traded between US$17.94 and US$38.37. On Syfe you can trade TEVA with $0 commission and add it to your watchlist.
| Previous close | US$37.62 |
|---|---|
| Market cap | US$43.51B |
| P/E ratio | 13.79 |
| 52-week range | US$17.94 – US$38.37 |
| Volume | 4.72M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Teva Pharmaceutical Industries Limited American Depositary Shares
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Year: 1982
Stay on top of TEVA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
